Transcript Document
Delineating Thyroid-Mediated Toxicity Pathways in an Amphibian Model System Michael W. Hornung, Sigmund J. Degitz, Joseph E. Tietge US Environmental Protection Agency Office of Research and Development National Health and Environmental Effects Research Laboratory Mid-Continent Ecology Division Duluth, MN, USA McKim Conference on Predictive Toxicology September 16-18, 2008 Duluth, MN Outline Brief background on MED thyroid research Approach to adverse outcome pathway research for amphibian-based thyroid model Investigating endpoints at steps in the pathway Understanding toxicity in the context of pathway information Background on EDC Assays FQPA and SDWA directed U.S. EPA to evaluate chemicals for endocrine disruption Endocrine Disrupter Screening and Testing Advisory Committee (EDSTAC) established Screening and testing methods recommended by EDSTAC included: • Short-term fish reproduction assay to detect HPG effects • Short-term amphibian metamorphosis assay to detect HPT effects • Longer-term fish life-cycle assay for reproductive effects • Longer-term amphibian reproductive/developmental effects Test Overview Prometamorphosis Climax 700 Concentration (ng/dL) Initiated with tadpoles at onset of thyroid function 14-21 days exposure Apical Endpoints • Developmental stage • Thyroid histology T4 T3 600 500 400 300 200 100 0 51 54 Thyroid function 60 Developmental Stage 66 Amphibian Metamorphosis Assay Methimazole Perchlorate 100 100 50 50 0 0 100 100 50 50 0 0 55 56 57 58 59 60 55 56 57 58 59 60 61 62 In Vivo Gene Expression Following Exposure NIS Gene Response 0.18 Copies NIS/Copies ACT 0.16 Control Methimazole Perchlorate Propylthiouracil 0.14 0.12 0.10 0.08 0.06 0.04 0.02 0.00 0 Day 0.5 Day 1 Day 1.5 Day 2 Day 4 Day 6 Exposure ----------------------------------------> response The Need for Predictive Tools Apical endpoints established with the amphibian metamorphosis assay. However we can not test all the chemicals for which little is known about thyroid activity Need to develop tools to aid in selecting chemicals that need to be tested and inform which chemicals are likely not active and do not need to be tested or can be assigned low priority for testing Potential Endpoints for Thyroid Hormone Disruption Hypothalamus TRH/CRH Tyrosine Iodination and Hormone Production Pituitary Thyroid Peroxidase TSH T4 (-) Thyroid Gland Iodine Uptake Sodium-Iodide Symporter MIT I + Tyr NIS Iodine TPO DIT DIT DIT T4 Metabolizing Enzyme Induction / Activity T4 Liver metabolism/ conjugation TH-gluc elimination T4 Receptor and Protein Binding Peripheral Tissue Deiodination T3 + TR T3-TR:RXR DNA mRNA Adverse Outcome Pathways for Thyroid Disruption Subcellular Target Cells Effected Methimazole TPO Enzyme Inhibition Thyroid Follicular Cells T4 Synthesis Perchlorate NIS Inhibition Thyroid Follicular Cells T4 Synthesis Chemical Tissue/Organ Adverse Outcome Serum T4 Systemic T4 Insufficiency Arrested Amphibian Metamorphosis Serum T4 Systemic T4 Insufficiency Arrested Amphibian Metamorphosis Toxicity Pathway Adverse Outcomes Pathway Amphibian Metamorphosis Assay Selection of a Pathway Chemical Methimazole Methimazole Subcellular Target TPO Enzyme Inhibition TPO Enzyme Inhibition Cells Effected Thyroid Follicular Cells Adverse Outcome Tissue/Organ Serum T4 Arrested Amphibian Metamorphosis Systemic T4 Insufficiency T4 Synthesis Thyroid Follicular Cells T4 Synthesis Serum T4 Increased Serum TSH TPO-inhibition has potentially more types of chemicals that can affect it than NIS. Assays available. Single chemical with potential for multiple adverse outcome pathways related to thyroid Goiter ? Thyroid Tumor ? Thyroid Explant Cultures and In Vitro Assays to Understand Responses Outside of the Compensatory Mechanisms of the Whole Animal Thyroid Gland Explant Cultures Ex Vivo: Thyroid Gland Explant Cultures Dissect thyroid glands from pro-metamorphic tadpoles • Culture in 96-well plates in L-15 media • Stimulate with TSH and treat with graded concentrations of test chemical • Measure T4 released to media by RIA • Measure TSH responsive gene expression by QPCR. TSH Chemical X T4 0.5 mm Paired thyroid glands in NF stage 59 X. laevis tadpole Adverse Outcomes Pathway for Thyroid Toxicity Chemical Methimazole Subcellular Target Cells Effected Thyroid Follicular Cells TPO Enzyme Inhibition Adverse Outcome Tissue/Organ Serum T4 Systemic T4 Insufficiency T4 Synthesis Arrested Amphibian Metamorphosis Toxicity Pathway Adverse Outcomes Pathway Methimazole TPO Enzyme Inhibition Thyroid Follicular Cells T4 Synthesis Inhibition of T4 released from glands Verification of chemical activity at organ level TSH T4 Thyroid Explant Culture Assay X Thyroid Gland Explant Culture: Time & dose relationship of T4 release inhibition T4 Released (ng T4 / mm3 gland / 24h) 400 1000 ng TSH/ml 1000 ng TSH/ml + MM1 2000 ng TSH/ml 2000 ng TSH/ml + MM1 300 200 100 0 1 2 3 4 5 Day 6 8 10 12 Gene Expression in Thyroid Gland Explant Cultures Gene Expression in Response to TSH TTF, NIS, and TPO 35000 Copies / ng RNA 30000 25000 Fresh 0h Control 24h No TSH 24h TSH 20000 15000 10000 5000 0 TTF NIS TPO Thyroid Gene Expression: Response to Inhibitors Methimazole, PTU, and Perchlorate Treatment TPO NIS Copies of NIS per RPL32 0.10 1.2 1.0 0.08 0.8 0.06 0.6 0.04 0.4 0.02 0.2 0.00 0.0 Fresh 0h (-) TSH 24h (-) TSH 24h (+) TSH Freshly Dissected No Inhibitor Fresh 0h (-) TSH Methimazole PTU Perchlorate 24h (-) TSH 24h (+) TSH Thyroid Explant Culture Interpretation of compensatory and direct effects In vitro… • Release T4 in response to TSH is dose related • T4 reserves must be depleted before synthesis inhibition significantly affects T4 release In vivo… • Early stages are more sensitive to arrested metamorphosis by T4 inhibitors than late stages • At late prometamorphosis, thyroid glands are larger and reserve T4 is sufficient to complete metamorphosis • Exposure time 0 does not equal effect time 0 for circulating T4: NEED TO UNDERSTAND DOSIMETRY / PK & PD • Need to measure circulating hormone levels (T4, TSH) to interpret gene expression and protein responses in vivo Inhibition of TSH-Stimulated T4 Release by Cultured Thyroid Glands Thyroid glands from X. laevis tadpoles (NF stage 59) were cultured in L-15 media in the presence of 2000 ng TSH/ml alone or TSH and graded concentrations of chemical. Media was collected and analyzed by RIA for T4. T4 Released (ng T4/ mm3 gland / 48h) 200 Methimazole Propylthiouracil Perchlorate IC50 = 1 µM 200 IC50 = 7 µM 200 175 175 175 150 150 150 125 125 125 100 100 100 75 75 75 50 50 50 25 25 25 0 0.001 0 0 0.1 1 10 100 Concentration (µM) IC50 = 11 µM 1 10 Concentration (µM) Perchlorate – Iodine uptake inhibition PTU & Methimazole – TPO inhibition Understand results in the context of the assay 100 1 10 Concentration (µM) 100 Assess Pathway for Thyroid Disruption vs Thyroid Follicular Cell Toxicity Chemical ??? mitochondria Adverse Outcome Tissue/Organ Thyroid Follicular Cells Inhibition of T4 released from glands T4 Synthesis Thyroid Follicular Cells MTT Assay for mito function Cell Death Thyroid Disrupting Chemical Thyroid Explant Culture Assay TSH T4 X Thyroid Toxic Chemical 100 100 Response (% of Control) Chemical TPO Enzyme Inhibition Cells Effected Response (% of Control) Chemical Subcellular Target 80 60 40 MTT T4 Release 20 80 60 40 MTT T4 Release 20 0 0 -12 -11 -10 -9 -8 -7 -6 Concentration (log M) -5 -4 -3 -12 -11 -10 -9 -8 -7 -6 Concentration (log M) -5 -4 -3 Chemical Testing and Predictive Model Development Ex Vivo T4 Release Inhibition In Vitro TPO Inhibition Chemical Selection In Vivo Amphibian Metamorphosis Assay Model T4 Synthesis Inhibitors QSAR Literature – Thyroid Toxicity Chemical Structure Similarities EPA Chemical Lists Adverse Outcomes Pathway for Thyroid Toxicity Chemical Methimazole Subcellular Target TPO Enzyme Inhibition Cells Effected Thyroid Follicular Cells T4 Synthesis Toxicity Pathway Methimazole TPO Enzyme Inhibition In Vitro TPO Inhibition Assay QSAR = Chemical + Cellular Target Tissue/Organ Serum T4 Serum TSH Systemic T4 Insufficiency Adverse Outcome Arrested Amphibian Metamorphosis Thyroid Peroxidase Inhibition In Vitro: Prepare microsomes containing thyroid peroxidase activity from pig thyroid glands Test chemicals for potency for inhibiting two TPO-mediated reactions 1. Tyrosine Iodination: Conversion of Tyrosine to MIT/DIT 2. Guaiacol Oxidation: Surrogate coupling reaction (DIT + DIT = T4) Guaiacol Oxidation Assay CH3 OH O CH3 O O TPO H2O2 H3C O O Abs (470 nm) Relative Potency of Model T4 Synthesis Inhibitors for TPO Inhibition Change in abs / min / mg protein 6 5 Methimazole PTU Perchlorate 4 IC50 (µM) 2.7 8.8 13,400 3 2 1 0 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 Concentration (log M) Methimazole is the most potent of the model T4 synthesis inhibitors in the TPO inhibition assay. Perchlorate had very low potency for TPO inhibition, but was the most potent of the three inhibitors in the ex vivo and in vivo assays. The primary mechanism of action for perchlorate inhibition of T4 synthesis is by inhibiting iodide uptake into the follicular cells. TPO Inhibition: Alkylphenol Series Change in abs/min/mg protein 6 5 4 3 Phenol Methylphenol Ethylphenol n-Propylphenol n-Butylphenol Methimazole 2 1 0 0 -7 -6 -5 -4 -3 -2 Concentration (log M) All alkylphenols tested exhibited no inhibition of TPO activity Screening Chemicals for Higher Tier Testing 24 chemicals tested in vitro in TPO Inhibition Assay Inactive Active 7 Inhibit TPO In Vitro Model TPO Inhibitors 17 Did Not Inhibit TPO N H3C N H N OH SH H N SH O S H N N CH3 O NH S CH3 - I + Cl O Na O O H N - I O O H2N H3C N O I N Cl OH CH3 Cl O Thyroid Gland Explant Culture: T4 Release Cytotoxic / Negative O H N - O H3C N N N N Cl Positive: Inhibits T4 Release OH H N SH Cl O CH3 S • Alkylphenol series • Phthalates • Isothiazoline • Mixed Iodo Phenyl • OH-PCDE • Triazole • Triazines • Conazole Test In Vivo Amphibian Metamorphosis Assay TPO Assay Summary The TPO assay can be used to rapidly screen chemicals for further testing in the higher level thyroid toxicity assays, and can be used to begin to develop predictive models incorporating structure activity relationships between chemical structure and T4 synthesis inhibition This suite of assays can be an effective tool to determine the capacity of previously untested or unsuspected classes of chemicals to disrupt normal thyroid hormone production Adverse Outcomes Pathways for Thyroid Disruption Chemical Methimazole Subcellular Target TPO Enzyme Inhibition Cells Effected Thyroid Follicular Cells Tissue/Organ Serum T4 T4 Synthesis Systemic T4 Insufficiency In Vitro - QSAR Ex Vivo Gland/Tissue Culture Toxicity Pathway Amphibian Metamorphosis Assay Adverse Outcomes Pathway Adverse Outcome Arrested Amphibian Metamorphosis MED Thyroid Project Team Mike Hornung Sig Degitz Joe Tietge John Nichols Jose Serrano Joe Korte Gary Holcombe Pat Kosian Dean Hammermeister Jon Haselman Brian Butterworth Sherri Batterman Post Docs Kara Thoemke Jasim Chowdhury Robin Sternberg Student Contractors Hollie Kerr Megan Bugge Lisa Korte Jessica Olson Emily Burgess Scott Moen